Common use of Protection and Marking Clause in Contracts

Protection and Marking. All Confidential Information of the Disclosing Party: (i) is to be held in strict confidence by the Receiving Party, (ii) is to be used by and under authority of the Receiving Party only as authorized in the Agreement, and (iii) shall not be disclosed by the Receiving Party, its agents or employees to any third party without the prior written consent of the Disclosing Party or as authorized in the Agreement. Licensee has the right to use and disclose Confidential Information of Licensor reasonably in connection with the exercise of its rights and performance of its obligations under the Agreement, including without limitation disclosing such Confidential Information to Sublicensees, potential investors, acquirers, and others on a need to know basis, if such Confidential Information is provided under conditions which reasonably protect the confidentiality thereof. The Receiving Party has the right to disclose the Disclosing Party’s Confidential Information to its agent and employees to the extent necessary for the Receiving Party to exercise its rights or perform its obligations under the Agreement, provided that each agent and employee receiving such Confidential Information is subject to appropriate confidentiality obligations substantially similar to those of this Section 8. Each Party’s obligation of confidence hereunder includes, without limitation, using at least the same degree of care with the disclosing Party’s Confidential Information as it uses to protect its own Confidential Information, but always at least a reasonable degree of care. The Receiving Party shall be solely liable for any disclosure or use of the Disclosing Party’s Confidential Information in violation of this Agreement by any agents, employees, advisors, actual or potential Sublicensees, acquirers or investors of the Receiving Party.

Appears in 5 contracts

Samples: Patent and Technology License Agreement (MAIA Biotechnology, Inc.), Patent and Technology License Agreement (MAIA Biotechnology, Inc.), Patent and Technology License Agreement (MAIA Biotechnology, Inc.)

AutoNDA by SimpleDocs

Protection and Marking. All Licensor and Licensee each agree that all Confidential Information disclosed in tangible form, and marked “confidential” and forwarded to one by the other, or if disclosed orally, is designated as confidential at the time of disclosure and summarized in a written document marked “confidential” and provided to the receiving Party within [***] after the date of the Disclosing Partyinitial disclosure: (ia) is to be held in strict confidence by the Receiving receiving Party, (iib) is to be used by and under authority of the Receiving Party receiving Part) only as authorized in this Agreement or the Sponsored Research Agreement, and (iiib) shall not be disclosed by the Receiving receiving Party, its agents or employees to any third party without the prior written consent of the Disclosing disclosing Party or as authorized in the Agreement. Licensee has the right to use and disclose Confidential Information of Licensor reasonably in connection with the exercise of its rights and performance of its obligations under the Agreement, including including, without limitation limitation, disclosing such Confidential Information to actual or potential Affiliates, Sublicensees, potential investors, acquirers, and others on a need to know basis, if such Confidential Information is provided under conditions which reasonably protect the confidentiality thereof. The Receiving Party has the right to disclose the Disclosing Party’s Confidential Information to its agent and employees to the extent necessary for the Receiving Party to exercise its rights or perform its obligations under the Agreement, provided that each agent and employee receiving such Confidential Information is subject to appropriate written confidentiality obligations substantially similar to those of as restrictive as this Section 8Article 10. Each Party’s obligation of confidence hereunder under this Agreement includes, without limitation, using at least the same degree of care with the disclosing Party’s Confidential Information as it uses to protect its own oval Confidential Information, but always at least a reasonable degree of care. The Receiving Party shall be solely liable for any disclosure or use of Notwithstanding the Disclosing Party’s Confidential Information marking requirements set forth in violation this Section 10.2, until published otherwise in the public domain through no breach of this Agreement all [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. EXECUTIVE VERSION invention disclosures, patentable subject matter and patent applications included in the Licensed Patents shall be subject to the restrictions in this Section 10.2 whether or not it is marked or identified as “confidential” by any agents, employees, advisors, actual or potential Sublicensees, acquirers or investors of the Receiving PartyLicensor.

Appears in 2 contracts

Samples: Exclusive License Agreement (Juno Therapeutics, Inc.), Exclusive License Agreement (Juno Therapeutics, Inc.)

Protection and Marking. All Licensor and Licensee each agree that all Confidential Information of disclosed in tangible form, and marked “confidential” and forwarded to one by the Disclosing Partyother, or if disclosed orally, is designated as confidential at the time of, disclosure: (i) is to to: be held in strict confidence by the Receiving receiving Party, (ii) is to be used by and under authority of the Receiving receiving Party only as authorized in the Agreement, and (iii) shall not be disclosed by the Receiving receiving Party, its agents or employees to any third party without the prior written consent of the Disclosing disclosing Party or as authorized in the Agreement. Licensee has the right to use and disclose Confidential Information of Licensor reasonably [***]Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Confidential treatment has been requested with respect to this information. Licensee: AEMase Inc. CONFIDENTIAL Exclusive PLA in connection with the exercise of its rights and performance of its obligations under the Agreement, including without limitation disclosing such Confidential Information to Affiliates, Sublicensees, potential investors, acquirers, and others on a need to know basis, if such Confidential Information is provided under conditions which reasonably protect the confidentiality thereof. The Receiving Party has the right to disclose the Disclosing Party’s Confidential Information to its agent and employees to the extent necessary for the Receiving Party to exercise its rights or perform its obligations under the Agreement, provided that each agent and employee receiving such Confidential Information is subject to appropriate confidentiality obligations substantially similar to those of this Section 8. Each Party’s obligation of confidence hereunder includes, without limitation, using at least the same degree of care with the disclosing Party’s Confidential Information as it uses to protect its own Confidential Information, but always at least a reasonable degree of care. The Receiving Party shall be solely liable for any disclosure or use of the Disclosing Party’s Confidential Information in violation of this Agreement by any agents, employees, advisors, actual or potential Sublicensees, acquirers or investors of the Receiving Party.

Appears in 2 contracts

Samples: Patent License Agreement (Aeglea BioTherapeutics, Inc.), Patent License Agreement (Aeglea BioTherapeutics, Inc.)

AutoNDA by SimpleDocs

Protection and Marking. All Confidential Information of the Disclosing Party: (i) is to be held in strict confidence by the Receiving Party, (ii) is to be used by and under authority of the Receiving Party only as authorized in the Agreement, and (iii) shall not be 21818479.1 238213-10001 14 disclosed by the Receiving Party, its agents or employees to any third party without the prior written consent of the Disclosing Party or as authorized in the Agreement. Licensee has the right to use and disclose Confidential Information of Licensor reasonably in connection with the exercise of its rights and performance of its obligations under the Agreement, including without limitation disclosing such Confidential Information to Sublicensees, potential investors, acquirers, and others on a need to know basis, if such Confidential Information is provided under conditions which reasonably protect the confidentiality thereof. The Receiving Party has the right to disclose the Disclosing Party’s Confidential Information to its agent and employees to the extent necessary for the Receiving Party to exercise its rights or perform its obligations under the Agreement, provided that each agent and employee receiving such Confidential Information is subject to appropriate confidentiality obligations substantially similar to those of this Section 8. Each Party’s obligation of confidence hereunder includes, without limitation, using at least the same degree of care with the disclosing Party’s Confidential Information as it uses to protect its own Confidential Information, but always at least a reasonable degree of care. The Receiving Party shall be solely liable for any disclosure or use of the Disclosing Party’s Confidential Information in violation of this Agreement by any agents, employees, advisors, actual or potential Sublicensees, acquirers or investors of the Receiving Party.

Appears in 1 contract

Samples: Patent and Technology License Agreement (MAIA Biotechnology, Inc.)

Time is Money Join Law Insider Premium to draft better contracts faster.